scholarly article | Q13442814 |
P50 | author | Maxime M Mahe | Q57498736 |
Andrew Elefanty | Q77343878 | ||
Edouard G Stanley | Q91105886 | ||
P2093 | author name string | Yuichiro Miyaoka | |
Bruce R Conklin | |||
Jacqueline Schiesser | |||
Mohammad A Mandegar | |||
Nambirajan Sundaram | |||
Michel Neunlist | |||
Philippe Aubert | |||
Michael A Helmrath | |||
Holly M Poling | |||
Carey L Watson | |||
James M Wells | |||
Ching-Fang Chang | |||
Samantha A Brugmann | |||
Michael J Workman | |||
Stephen Trisno | |||
P2860 | cites work | CHD7 cooperates with PBAF to control multipotent neural crest formation | Q24630725 |
White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies | Q26750556 | ||
Distinct roles for Fgf, Wnt and retinoic acid in posteriorizing the neural ectoderm | Q28312224 | ||
The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives | Q28505510 | ||
Expression of Ret-, p75(NTR)-, Phox2a-, Phox2b-, and tyrosine hydroxylase-immunoreactivity by undifferentiated neural crest-derived cells and different classes of enteric neurons in the embryonic mouse gut | Q28591270 | ||
REVIGO summarizes and visualizes long lists of gene ontology terms | Q29614817 | ||
Ultrasensitive fluorescent proteins for imaging neuronal activity | Q29616778 | ||
Genetic engineering of human pluripotent cells using TALE nucleases | Q29619830 | ||
Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells | Q30619796 | ||
Appearance of cholinergic myenteric neurons during enteric nervous system development: comparison of different ChAT fluorescent mouse reporter lines. | Q33680578 | ||
Isolation of single-base genome-edited human iPS cells without antibiotic selection | Q33776890 | ||
The enteric nervous system | Q34250716 | ||
Organogenesis in a dish: modeling development and disease using organoid technologies | Q34429586 | ||
ToppGene Suite for gene list enrichment analysis and candidate gene prioritization | Q34982758 | ||
Microbiota controls the homeostasis of glial cells in the gut lamina propria | Q35013616 | ||
An in vivo model of human small intestine using pluripotent stem cells | Q35533803 | ||
Development of enteric neuron diversity. | Q35832069 | ||
Transplanted progenitors generate functional enteric neurons in the postnatal colon | Q36638182 | ||
Deriving human ENS lineages for cell therapy and drug discovery in Hirschsprung disease | Q36839772 | ||
Birthdating of myenteric neuron subtypes in the small intestine of the mouse | Q37423421 | ||
Generating human intestinal tissue from pluripotent stem cells in vitro | Q37495400 | ||
Development of the enteric nervous system and its role in intestinal motility during fetal and early postnatal stages. | Q37603670 | ||
Multipotent caudal neural progenitors derived from human pluripotent stem cells that give rise to lineages of the central and peripheral nervous system. | Q37696446 | ||
The enteric nervous system and neurogastroenterology. | Q37990818 | ||
Development and developmental disorders of the enteric nervous system | Q38066359 | ||
Cellular changes in the enteric nervous system during ageing | Q38093934 | ||
Hirschsprung disease: a developmental disorder of the enteric nervous system. | Q38116935 | ||
Distinct subpopulations of enteric neuronal progenitors defined by time of development, sympathoadrenal lineage markers and Mash-1-dependence. | Q38287443 | ||
Enteric nervous system assembly: Functional integration within the developing gut. | Q38846945 | ||
Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales | Q39109857 | ||
Faithful expression of multiple proteins via 2A-peptide self-processing: a versatile and reliable method for manipulating brain circuits. | Q39827307 | ||
A method for genetic modification of human embryonic stem cells using electroporation | Q40143374 | ||
GDNF is a chemoattractant for enteric neural cells. | Q40833233 | ||
Transient catecholaminergic (TC) cells in the vagus nerves and bowel of fetal mice: relationship to the development of enteric neurons | Q41275572 | ||
Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro | Q41770080 | ||
Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs | Q42153574 | ||
Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease | Q43090325 | ||
Neural stem cell therapies for enteric nervous system disorders | Q43617676 | ||
Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes | Q44357603 | ||
Perturbation of hoxb5 signaling in vagal neural crests down-regulates ret leading to intestinal hypoganglionosis in mice | Q46659431 | ||
Congenital central hypoventilation syndrome and Hirschsprung's disease in an extremely preterm infant | Q47787585 | ||
Embryonic development of the ganglion plexuses and the concentric layer structure of human gut: a topographical study. | Q48021523 | ||
Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. | Q50856695 | ||
HOXB5 expression is spatially and temporarily regulated in human embryonic gut during neural crest cell colonization and differentiation of enteric neuroblasts. | Q52100965 | ||
Development of the enteric nervous system, smooth muscle and interstitial cells of Cajal in the human gastrointestinal tract | Q81322487 | ||
Human and mouse enteric nervous system neurosphere transplants regulate the function of aganglionic embryonic distal colon | Q81366321 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nervous system | Q9404 |
pluripotency | Q1894941 | ||
P304 | page(s) | 49-59 | |
P577 | publication date | 2016-11-21 | |
P1433 | published in | Nature Medicine | Q1633234 |
P1476 | title | Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system | |
P478 | volume | 23 |
Q90403541 | Addressing Patient Specificity in the Engineering of Tumor Models |
Q45945719 | Advances in paediatric gastroenterology. |
Q47284750 | Advancing Intestinal Organoid Technology Toward Regenerative Medicine |
Q52568381 | Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease. |
Q66679557 | All Together Now: Modeling the Interaction of Neural With Non-neural Systems Using Organoid Models |
Q92335069 | An Efficient Intestinal Organoid System of Direct Sorting to Evaluate Stem Cell Competition in Vitro |
Q89379618 | Are We Close to Targeting Enteric Glia in Gastrointestinal Diseases and Motility Disorders? |
Q52714746 | Bioengineered intestinal muscularis complexes with long-term spontaneous and periodic contractions. |
Q42265138 | Bioengineering of functional human induced pluripotent stem cell-derived intestinal grafts. |
Q93137039 | Biologically inspired approaches to enhance human organoid complexity |
Q91658907 | Blockade of STAT3 Causes Severe In Vitro and In Vivo Maturation Defects in Intestinal Organoids Derived from Human Embryonic Stem Cells |
Q93137030 | Brain organoids: advances, applications and challenges |
Q39139678 | Cell therapy for GI motility disorders: comparison of cell sources and proposed steps for treating Hirschsprung disease. |
Q88262309 | Chick midgut morphogenesis |
Q50133827 | Delivery of Mesenchymal Stem Cells from Gelatin-Alginate Hydrogels to Stomach Lumen for Treatment of Gastroparesis |
Q92615456 | Derivation of enteric neuron lineages from human pluripotent stem cells |
Q90715625 | Diabetes through a 3D lens: organoid models |
Q39312412 | Diagnostic and Research Aspects of Small Intestinal Disaccharidases in Coeliac Disease |
Q91626722 | Digitalized Human Organoid for Wireless Phenotyping |
Q40382652 | Disease in three dimensions: Tissue engineering takes on infectious disease |
Q66678801 | Disease modelling in human organoids |
Q52575752 | Engineered Human Gastrointestinal Cultures to Study the Microbiome and Infectious Diseases. |
Q89106932 | Engineering a second brain in a dish |
Q58102543 | Engineering induction of singular neural rosette emergence within hPSC-derived tissues |
Q52313815 | Enteric Nervous System Regulation of Intestinal Stem Cell Differentiation and Epithelial Monolayer Function. |
Q38558481 | Enteric nervous system development: A crest cell's journey from neural tube to colon. |
Q47414413 | Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology |
Q58614050 | From single cells to tissue self-organization |
Q61797566 | Gastrointestinal Dysmotility in MNGIE: from thymidine phosphorylase enzyme deficiency to altered interstitial cells of Cajal |
Q40189708 | Gastrointestinal microphysiological systems |
Q89900769 | Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches |
Q93336621 | Generation of human antral and fundic gastric organoids from pluripotent stem cells |
Q91583998 | Generation of intestinal organoids derived from human pluripotent stem cells for drug testing |
Q33628093 | Genome engineering of stem cell organoids for disease modeling |
Q64100765 | Gut bioengineering promotes gut repair and pharmaceutical research: a review |
Q92763088 | Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology |
Q50196075 | Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes |
Q47691807 | Host-microbe interaction in the gastrointestinal tract. |
Q64110789 | Human Pluripotent Stem Cell-Derived Neural Crest Cells for Tissue Regeneration and Disease Modeling |
Q47105459 | Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology |
Q38707919 | In Vitro Models to Study Human Lung Development, Disease and Homeostasis. |
Q46150911 | Induced pluripotent stem cells derived from human amnion in chemically defined conditions. |
Q91430090 | Induced pluripotent stem cells in disease modelling and drug discovery |
Q96576026 | Innervation: the missing link for biofabricated tissues and organs |
Q92759926 | Insights Into Human Development and Disease From Human Pluripotent Stem Cell Derived Intestinal Organoids |
Q39388017 | Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier. |
Q90295269 | Intestinal organoids in infants and children |
Q58587561 | Isolation and characterisation of mouse intestinal mesoangioblasts |
Q63952212 | Mechanically induced development and maturation of human intestinal organoids in vivo |
Q55640344 | Microenvironment of a tumor-organoid system enhances hepatocellular carcinoma malignancy-related hallmarks. |
Q59133328 | Modeling Host-Pathogen Interactions in the Context of the Microenvironment: Three-Dimensional Cell Culture Comes of Age |
Q51417867 | Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond. |
Q39119942 | Morphogenesis and maturation of the embryonic and postnatal intestine |
Q90110358 | Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery |
Q41062627 | Neural Crest Cell Implantation Restores Enteric Nervous System Function and Alters the Gastrointestinal Transcriptome in Human Tissue-Engineered Small Intestine |
Q51091027 | Neurogastroenterology: Engineering human intestinal organoids with a functional ENS. |
Q90699508 | Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium |
Q95457417 | Oesophageal atresia |
Q47562383 | Opportunities for organoids as new models of aging |
Q49565648 | Optogenetic and chemogenetic techniques for neurogastroenterology. |
Q93054814 | Organ-On-A-Chip in vitro Models of the Brain and the Blood-Brain Barrier and Their Value to Study the Microbiota-Gut-Brain Axis in Neurodegeneration |
Q99636824 | Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review |
Q58737628 | Organoid technology and applications in cancer research |
Q91615027 | Organoids - New Models for Host-Helminth Interactions |
Q52564853 | Organoids in cancer research. |
Q49750800 | Organoids recapitulate organs? |
Q88184003 | Organoids: a better in vitro model |
Q63740160 | Organs to Cells and Cells to Organoids: The Evolution of Central Nervous System Modelling |
Q99350419 | Organs-on-chips: into the next decade |
Q39178341 | Pluripotent stem cell-derived organoids: using principles of developmental biology to grow human tissues in a dish |
Q91987433 | Present and Future Perspectives of Using Human-Induced Pluripotent Stem Cells and Organoid Against Liver Failure |
Q57032267 | Production of Tissue-Engineered Small Intestine in Rats with Different Ages of Cell Donors |
Q61053075 | Progress and potential in organoid research |
Q47668090 | Regenerating human epithelia with cultured stem cells: feeder cells, organoids and beyond. |
Q50428928 | Regenerative Medicine: Advances from Developmental to Degenerative Diseases. |
Q47274655 | Regenerative medicine for the esophagus. |
Q102075512 | Rethinking organoid technology through bioengineering |
Q89955562 | Robust, 3-Dimensional Visualization of Human Colon Enteric Nervous System Without Tissue Sectioning |
Q90595420 | Smooth muscle contractility causes the gut to grow anisotropically |
Q39373980 | Stem Cells in Repair of Gastrointestinal Epithelia |
Q39229334 | Stem cell-derived organoids and their application for medical research and patient treatment |
Q91977175 | Stem cells in tissues, organoids, and cancers |
Q52594395 | The Development of Newborn Porcine Models for Evaluation of Tissue Engineered Small Intestine. |
Q59360163 | The Dual Tropism of Noroviruses |
Q92159179 | The Enteric Nervous System for Epithelial Researchers: Basic Anatomy, Techniques, and Interactions With the Epithelium |
Q90333439 | The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge |
Q94455850 | The Microbiome and the Gut-Liver-Brain Axis for CNS Clinical Pharmacology: Challenges in Specifying and Integrating In Vitro and In Silico Models |
Q47102897 | The Potential for Gut Organoid Derived Interstitial Cells of Cajal in Replacement Therapy |
Q102141773 | The promise of human organoids in the digestive system |
Q47842599 | The rise of three-dimensional human brain cultures |
Q90128191 | Tissue Responses to Shiga Toxin in Human Intestinal Organoids |
Q47646913 | Tissue engineering for the treatment of short bowel syndrome in children |
Q42376262 | Top-Down Inhibition of BMP Signaling Enables Robust Induction of hPSCs Into Neural Crest in Fully Defined, Xeno-free Conditions |
Q39329872 | Toward a CRISPR Picture: Use of CRISPR/Cas9 to Model Diseases in Human Stem Cells In Vitro |
Q51733132 | Translating Developmental Principles to Generate Human Gastric Organoids. |
Q99631269 | Translating Embryogenesis to Generate Organoids: Novel Approaches to Personalized Medicine |
Q90720505 | Transplantation of human intestinal organoids into the mouse mesentery: A more physiologic and anatomic engraftment site |
Q39306080 | Update on Foregut Molecular Embryology and Role of Regenerative Medicine Therapies |
Q90559786 | Use of organoids to study regenerative responses to intestinal damage |
Q101403284 | Using multi-organ culture systems to study Parkinson's disease |
Search more.